0001437749-16-037322.txt : 20160812 0001437749-16-037322.hdr.sgml : 20160812 20160812162125 ACCESSION NUMBER: 0001437749-16-037322 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160811 FILED AS OF DATE: 20160812 DATE AS OF CHANGE: 20160812 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aviragen Therapeutics, Inc. CENTRAL INDEX KEY: 0000072444 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 591212264 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100 CITY: ALPHARETTA STATE: 2Q ZIP: 30009 BUSINESS PHONE: 301-770-3099 MAIL ADDRESS: STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100 CITY: ALPHARETTA STATE: 2Q ZIP: 30009 FORMER COMPANY: FORMER CONFORMED NAME: Biota Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20121113 FORMER COMPANY: FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS DATE OF NAME CHANGE: 20100719 FORMER COMPANY: FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS DATE OF NAME CHANGE: 20020304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PATTI JOSEPH M CENTRAL INDEX KEY: 0001283215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35285 FILM NUMBER: 161828493 MAIL ADDRESS: STREET 1: 12270 WILKINS AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20852 4 1 rdgdoc.xml FORM 4 X0306 4 2016-08-11 0000072444 Aviragen Therapeutics, Inc. AVIR 0001283215 PATTI JOSEPH M 2500 NORTHWINDS PARKWAY STE 100 ALPHARETTA GA 30009 1 1 CEO Stock Option (Right to Buy) 1.30 2016-08-11 4 A 0 380000 1.30 A 2017-08-11 2026-08-11 Common Stock 380000 1478929 D The stock option vests in equal annual installments beginning on the first anniversary and thereafter on the second and third anniversary ratably. /s/ Joseph M. Patti 2016-08-12